Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Completed
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT01243255
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Patients on lipid lowering drug treatment
- Lipid lowering drug treatment lasting at least 3 months
- No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study
Exclusion Criteria
- Lack of patient's signed informed consent form
- Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general. whole study procedure takes place during the one, single patient's visit
- Secondary Outcome Measures
Name Time Method identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia. whole study procedure takes place during the one, single patient's visit establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population whole study procedure takes place during the one, single patient's visit establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population whole study procedure takes place during the one, single patient's visit
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie LDL cholesterol reduction in Polish hypercholesterolemia patients treated with lipid-lowering therapies?
How does the efficacy of AstraZeneca's lipid-lowering agents compare to standard-of-care statins in achieving ESC 2007 LDL goals?
Which biomarkers correlate with successful LDL cholesterol goal attainment in NCT01243255 observational study of hypercholesterolemia treatment?
What adverse event profiles are associated with non-statins lipid-lowering therapies in European hypercholesterolemia treatment guidelines?
How do combination therapies involving ezetimibe and PCSK9 inhibitors impact LDL management compared to monotherapies in Polish cardiovascular patients?